Mathieu Degomme

Mathieu Degomme is the Global Head of CMC oral and semi-solid portfolio at Galderma. They previously held roles in various pharmaceutical companies, including Catalent Pharma Solutions, Boiron France, Aenova, and Skyepharma, where they specialized in quality assurance and project management. Mathieu earned a Master's degree in Development and Production of Health Products from IPIL and a Doctorate in Pharmacy from Université de Limoges. Their expertise includes managing large project teams and overseeing regulatory compliance for FDA certification and product transfers.